This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 8 print issues and online access
$259.00 per year
only $32.38 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Ermis E, Ozbay Ozyilmaz S, Salabas E, Senol C, Cengiz M, Allahverdiyev S, et al. The relationship between erectile dysfunction and the atherogenic index of plasma. Int J Impot Res. 2019. https://doi.org/10.1038/s41443-019-0167-2.
Dobiasova M. Atherogenic index of plasma [log(triglycerides/HDL-cholesterol)]: theoretical and practical implications. Clin Chem. 2004;50:1113–5.
Kalelioğlu T, Ünalan P, Kök B, Sözen Ş, Yüksel Ö, Akkuş M. Atherogenic index of plasma as a cardiovascular risk marker in manic, depressive, and euthymic stages of bipolar disorder. Turk Kardiyol Dern Ars. 2018;46:32–8.
Bhardwaj S, Bhattacharijee J, Bhatnagar MK, Tyagi S. Atherogenic index of plasma, castelli risk index and atherogenic coefficient—new parameters in assessing cardiovascular risk. Int J Pharm Biol Sci. 2013;3:359–64.
Ventimiglia E, Cazzaniga W, Pederzoli F, Frego N, Chierigo F, Capogrosso P, et al. The role of neutrophil-to-lymphocyte ratio in men with erectile dysfunction-preliminary findings of a real-life cross-sectional study. Andrology. 2018;6:559–63.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ermis, E., Ozbay Ozyilmaz, S., Salabas, E. et al. Authors’ reply. Int J Impot Res 33, 126–127 (2021). https://doi.org/10.1038/s41443-020-0245-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41443-020-0245-5